An2 Therapeutics, Inc. (ANTX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:
0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
2
(1)
2
0
8
+1
0
+2
0
+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
18-Jan-24 6:18 PM
View: 		16-Jan-24
Sale
($312.57K)
Adjuvant Global Health Tech...
10% Owner
Insider Trading Sentiment for Adjuvant Global Health Technology Fund, L.P. at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(4%)
2.47M to 2.37M		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:27 PM
View: 		15-Mar-24
Grant
0
Chanda Sanjay
Chief Development Officer
Insider Trading Sentiment for Chanda Sanjay at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX3741%
0.73K to 28.23K		0
0
---- Show TxnsShow Insider Trades
18-Nov-24 8:51 PM
View: 		18-Nov-24
Private Purchase
$49.97K
Easom Eric
Chief Executive Officer
Director
Insider Trading Sentiment for Easom Eric at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX12%
1.21M to 1.36M		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:29 PM
View: 		15-Mar-24
Grant
0
Day Lucy
Chief Financial Officer
Insider Trading Sentiment for Day Lucy at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX879%
3.13K to 30.63K		0
0
---- Show TxnsShow Insider Trades
Yesterday 6:00 PM
View: 		20-Nov-24
Purchase
$57.87K
Readnour Robin Shane
Director
Insider Trading Sentiment for Readnour Robin Shane at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX22%
904.96K to 1.1M		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:27 PM
View: 		15-Mar-24
Grant
0
Eckburg Paul
Chief Medical Officer
Insider Trading Sentiment for Eckburg Paul at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX140%
21.42K to 51.42K		0
0
---- Show TxnsShow Insider Trades
20-Nov-24 4:11 PM
View: 		19-Nov-24
Purchase
$5.05K
Zakrzewski Joseph S
Director
Insider Trading Sentiment for Zakrzewski Joseph S at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(12%)
604.08K to 529.08K		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:28 PM
View: 		15-Mar-24
Grant
0
Krause Kevin Michael
Chief Strategy Officer
Insider Trading Sentiment for Krause Kevin Michael at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX1567%
1.91K to 31.91K		0
0
---- Show TxnsShow Insider Trades
13-Aug-24 5:03 PM
View: 		09-Aug-24
Sale
($3.81M)
Ra Capital Management, LLC
10% Owner
Insider Trading Sentiment for Ra Capital Management, LLC at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(64%)
5.55M to 2.03M		0
0
---- Show TxnsShow Insider Trades
12-Jul-24 4:13 PM
View: 		10-Jul-24
Grant
0
Eizen Joshua M
Chief Legal Officer
Insider Trading Sentiment for Eizen Joshua M at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX3775%
2.45K to 94.83K		0
0
---- Show TxnsShow Insider Trades
18-Jan-24 6:19 PM
View: 		16-Jan-24
Private Sale
($1.96M)
Aziz Kabeer
Director
Insider Trading Sentiment for Aziz Kabeer at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(4%)
2.47M to 2.37M		0
0
---- Show TxnsShow Insider Trades
14-Aug-24 8:24 PM
View: 		14-Aug-24
Private Purchase
$1.56M
Leonard Braden Michael
10% Owner
Insider Trading Sentiment for Leonard Braden Michael at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX35%
4.25M to 5.75M		0
0
---- Show TxnsShow Insider Trades